Kindred nabs Genentech vet as legal chief; VetStem forms partnership to expand stem cell use; Research group predicts steady growth of animal health industry;

> Kindred Biosciences ($KIN) announced that it has appointed Jennifer Elliott, formerly of Genentech, as vice president of legal affairs and intellectual property. Release

> VetStem Biopharma announced that it has formed an alliance with Veterinary Growth Partners centered around expanding the use of stem cell therapy in the treatment of dogs with arthritis. Release

> Future Market Insights (FMI) has published a report predicting that the animal health market, now valued at $32 billion a year, will expand at a compound annual growth rate of 5.1% through 2020. Release

> Catherine "Cat" Sayer, director of Forum Animal Health, has been named chair of the U.K.'s National Office of Animal Health. Release

> Researchers at the London School of Hygiene & Tropical Medicine and University of Malaysia Sarawak have published a study showing that a form of malaria that is transmitted from macaques to people is caused by two distinct parasite subpopulations associated with different monkey host species in Malaysia. Release

> The state of Michigan confirmed its first case of chronic wasting disease (CWD) in a wild white-tailed deer. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…